RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aug. 30, 2006--Theragenex, LLC, a pharmaceutical development company, announced today that it has signed a licensing agreement with Zylera Pharmaceuticals, covering a broad range of therapeutic areas for use with their patented pharmaceutical products addressing diabetes and complications of diabetes, as well as cardiovascular disease, osteoporosis and osteoarthritis.
